Our results demonstrated that the E. coli + OT-I group exhibited remarkable therapeutic efficacy, achieving tumor eradication in 4 out of 7 in primary tumors and 3 out of 7 in distal tumors (Fig. 4g, h). This evidence concerns the gene OXT and neoplasm.